Potential Human POC Diagnostics
Infectious diseases
ResearchActive
Key Facts
About MatMaCorp
MatMaCorp is a private diagnostics company pioneering portable, user-friendly molecular analysis systems to decentralize genetic testing. Its core technology platform integrates sample preparation, amplification, and detection into compact instruments designed for use in non-laboratory environments like farms, clinics, and field sites. The company primarily targets the agricultural and veterinary diagnostics markets with applications in pathogen detection and genetic trait analysis, positioning itself at the intersection of biotechnology and portable instrumentation. As a privately held firm, it likely operates with venture capital or grant funding, focusing on commercializing its platform and expanding its assay menu.
View full company profileOther Infectious diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| inPROBE Platform | SDS Optic | Early R&D |
| Nanoparticle Vaccines | Opko Health | Research |
| Platform Vaccine Applications | Chimeron Bio | Discovery |
| FMN riboswitch modulator | Acellera | Pre-clinical |
| NP-G2-044 | Novita Pharmaceuticals | Pre-Clinical |
| Ramoplanin™ | Nanopharmaceutics | Clinical |
| NanoDOX™ | Nanopharmaceutics | Clinical |
| Infectious Diseases | Menarini | Clinical |
| Undisclosed Infectious Disease Program(s) | ATB therapeutics | Pre-clinical |
| Vaccines for Infectious Diseases (undisclosed) | Takis | Pre-clinical |
| Infectious Disease Diagnostics Program | Aptus Biosciences | Discovery |
| Undisclosed Multispecific Therapeutics | ModeX Therapeutics | Pre-clinical |